author-photo

Steven Fakharzadeh

Janssen Pharmaceutica
University of Pennsylvania

48

Papers

2079

Citations

Citation Trend

Filter By

Papers (32) Sort By

Journal Conference Others

Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR.

2021 Drug Safety
Show All
- Source
- Cite
- Save
Citations (0)
27078 Mediation analysis of independent treatment effect of guselkumab on health-related quality of life in patients with moderate to severe plaque-type psoriasis: Results from 2 phase 3 studies VOYAGE-1&2

2021 Journal of The American Academy of Dermatology
Show All
- Source
- Cite
- Save
Citations (0)
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.

2021 Journal of The American Academy of Dermatology
Show All
- Source
- Cite
- Save
Citations (1)
Reduced Risk of Mortality Associated With Systemic Psoriasis Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A Nested Case-Control Analysis

2020 Journal of The American Academy of Dermatology
Show All
- Source
- Cite
- Save
Citations (7)
Targeting IL-23p19 with guselkumab; a highly effective and durable therapy for psoriasis

2019
- Steven Fakharzadeh
Show All
- Source
- Cite
- Save
Citations (0)
Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial

2018 Journal of Investigative Dermatology
Show All
- Source
- Cite
- Save
Citations (23)
Risk of malignancies associated with ustekinumab

2018 British Journal of Dermatology
Show All
- Source
- Cite
- Save
Citations (3)
Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

2018 British Journal of Dermatology
Show All
- Source
- Cite
- Save
Citations (8)
Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.

2017 Journal of Drugs in Dermatology
Show All
- Source
- Cite
- Save
Citations (16)
Extension of ustekinumab maintenance dosing interval in moderate‐to‐severe psoriasis: results of a phase IIIb, randomized, double‐blinded, active‐controlled, multicentre study (PSTELLAR)

2017 British Journal of Dermatology
Show All
- Source
- Cite
- Save
Citations (26)